L Quaranta, T Pizzolante, I Riva, AB Haidich … - British Medical Journal, 2008 - bjo.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 1 - Related articles - All 2 versions
L Quaranta, T Pizzolante, I Riva… - bjo.bmj.com Page 1. doi: 10.1136/bjo.2008.138024 published online June 27, 2008 Br J Ophthalmol
Luciano Quaranta, Teodoro Pizzolante, Ivano Riva, et al. ... Related articles
A Lafuma, G Berdeaux - Current Medical Research and Opinion®, 2007 - informahealthcare.com Objective: To compare the effectiveness and associated costs of travoprost
versus a fixed combination of dorzolamide + timolol as first-line therapy for
glaucoma according to data collected by the United Kingdom General ... Cited by 5 - Related articles - BL Direct - All 3 versions
I Kimura, K Shinoda, T Tanino, Y Ohtake, Y … - Japanese journal of ophthalmology, 2005 - Springer Unoprostone isopropyl is a chemically synthesized docosanoid (22-carbon basic
skeleton) that has been exten- sively evaluated by laboratory 1–3 and clinical
4–14 studies.The results of a clinical trial suggested that twice daily ... Cited by 4 - Related articles - All 4 versions
- ►iovs.org L Quaranta, S Miglior, I Floriani, T Pizzolante … - Investigative Ophthalmology & Visual Science, 2008 - ARVO METHODS. This was an institutional, randomized clinical trial. After a 24-hour
assessment without treatment, 27 previously untreated patients with POAG were
randomized to 6 weeks' treatment with twice-daily TDFC (8 AM and 8 PM) ... Cited by 4 - Related articles - All 4 versions
W Trattler, RJ Noecker, ML Earl - Advances in Therapy, 2008 - Springer Introduction: The aim of this study was to evaluate the incidence of hyper-
aemia in patients using bimatoprost and to determine if simple interventions
result in increased understanding of glaucoma and hyperaemia. Methods: This ... Cited by 5 - Related articles - BL Direct - All 3 versions
N Yildirim, A Sahin, S Gultekin - Journal of Glaucoma, 2008 - journals.lww.com The Effect of Latanoprost, Bimatoprost, and Travoprost ... Nilgun Yildirim, MD,
Afsun Sahin, MD, and Saadet Gultekin, MD ... Purpose: To evaluate the efficacy
of latanoprost, bimatoprost, and travoprost given in the evening over the ... Cited by 5 - Related articles - BL Direct - All 2 versions
A Sutton, A Gilvarry, A Ropo - Journal of Ocular Pharmacology and Therapeutics, 2007 - liebertonline.com ANDREW SUTTON, 1 ANNE GILVARRY, 2 and AULI ROPO 3 ... Objective: The aim of
this study was to determine the safety, tolerability, and pharmaco- dynamics of
a novel prostanoid fluoroprostaglandin (FP)-receptor agonist, tafluprost ... Cited by 6 - Related articles - BL Direct - All 3 versions
ED Sharpe, CJ Henry, TK Mundorf, DG Day, JA … - Eye, 2004 - nature.com In this prospective, multi-centred, double-masked, crossover comparison,
patients were randomized to one treatment group for a 6-week treatment period,
and then crossed over to the opposite treatment. Measurements were ... Cited by 7 - Related articles - All 3 versions
- ►iovs.org SFE Nilsson, E Drecoll, E Lutjen-Drecoll, CB … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. All experiments were performed in cynomolgus monkeys after topical
application of butaprost (0.1%). The effects of butaprost on aqueous humor flow
were determined by fluorophotometry. Total outflow facility was measured by ... Cited by 7 - Related articles - BL Direct - All 4 versions
